Neostigmine Methylsulfate Injection
Product Images NDC 42023-189

3 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 42023-189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Neostigmine Methylsulfate 1)

Structure (Neostigmine Methylsulfate 1)
Chemical structure of Neostigmine Methylsulfate, showing the molecular composition C13H22N2O6S with a molecular weight of 334.39.*
FDA Label Image

5mg/10ml Carton (Neostigmine Methylsulfate 2)

5mg/10ml Carton (Neostigmine Methylsulfate 2)
Packaging label for Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) by Par Health USA, LLC. The label indicates it is for intravenous use and contains 10 vials of 10 mL multiple-dose injections. Includes Rx only designation and storage instructions.*
FDA Label Image

10mg/10ml Carton (Neostigmine Methylsulfate 3)

10mg/10ml Carton (Neostigmine Methylsulfate 3)
Packaging label for Neostigmine Methylsulfate Injection, USP, 10 mg/10 mL (1 mg/mL) for intravenous use. The label indicates this is a multiple dose vial package containing 10 x 10 mL vials. Manufactured for Par Health USA, the label includes storage instructions and notes preservative and pH adjustment ingredients. The label prominently displays the NDC 42023-189-10 and Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.